Conibear J, Chia B, Ngai Y, et al. Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer. BMJ Open 2018;8:e020690. doi: 10.1136/bmjopen-2017-020690.
The previous version of this manuscript contains an errors in authors lists that were left out as well as the Contributors statement. It should appear as follows:
John Conibear
Brendan Chia
Yenting Ngai
Andrew Tom Bates
Nicholas Counsell
Rushil Patel
David Eaton
Corinne Faivre-Finn
John Fenwick
Martin Forster
Gerard G Hanna
Susan Harden
Philip Mayles
Syed Moinuddin
David Landau
Kevin Franks
Merina Ahmed
Stephen Harrow
Ruheena Mendes
Paul Hatfield
Yat Man Tsang
Ka Man Mak
Laura Farrelly
Instead of
John Conibear
Brendan Chia
Yenting Ngai
Andrew Tom Bates
Nicholas Counsell
Rushil Patel
David Eaton
Corinne Faivre-Finn
John Fenwick
Martin Forster
Gerard G Hanna
Susan Harden
Philip Mayles
Syed Moinuddin
David Landau
And
DL conceived of the study and is the grant holder. DL, JC, ATB, CF-F, JF, MF, GGH, PM, SM, SH, NC, YN, DE, RP, BC, KF, MA, SH, RM, PH, YMT, KMM and LF initiated, developed and planned the study design. NC also provided statistical expertise in clinical trial design. RP and DE also developed the radiotherapy quality assurance programme for the trial. All the authors contributed to refinement of the study protocol and approved the final manuscript. All contributors have been heavily involved in the design of the trial and have been involved in the drafting and review of the article to be published.
Instead of
DL conceived of the study and is the grant holder. DL, JC, ATB, CF-F, JF, MF, GGH, PM, SM, SH, NC, YN, DE, RP and BC initiated, developed and planned the study design. NC also provided statistical expertise in clinical trial design. RP and DE also developed the radiotherapy quality assurance programme for the trial. All the authors contributed to refinement of the study protocol and approved the final manuscript. All contributors have been heavily involved in the design of the trial and have been involved in the drafting and review of the article to be published.